Placebo mechanisms across different conditions: From the clinical setting to physical performance

Philosophical Transactions of the Royal Society B: Biological Sciences

Volumn 366, Issue 1572, 2011, Pages 1790-1798

  Pollo, Antonella ^a   Carlino, Elisa ^a   Benedetti, Fabrizio ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Conditioning; Expectation; Nocebo; Pain; Physical performance; Placebo

Indexed keywords

DOSE-RESPONSE RELATIONSHIP; DRUG; LABORATORY METHOD; NEUROLOGY; PATHOLOGY; PSYCHOLOGY;

AUTONOMIC NERVOUS SYSTEM; AUTONOMIC NEUROPATHY; BRAIN; CARDIOVASCULAR SYSTEM; EXERCISE; GASTROINTESTINAL TRACT; HUMAN; PAIN; PATHOPHYSIOLOGY; PHYSIOLOGY; PLACEBO EFFECT; RESPIRATORY SYSTEM; REVIEW;

AUTONOMIC NERVOUS SYSTEM; AUTONOMIC NERVOUS SYSTEM DISEASES; BRAIN; CARDIOVASCULAR SYSTEM; EXERCISE; GASTROINTESTINAL TRACT; HUMANS; PAIN; PLACEBO EFFECT; RESPIRATORY SYSTEM;

EID: 79956343829     PISSN: 09628436     EISSN: 14712970     Source Type: Journal    
DOI: 10.1098/rstb.2010.0381     Document Type: Review

References (82)

1. Benedetti, F. 2008 Placebo effects: understanding the mechanisms in health and disease. Oxford, UK: Oxford University Press.
2. Benedetti, F. 2010 The patient's brain: the neuroscience behind the doctor-patient relationship. Oxford, UK: Oxford University Press.
3. Benedetti, F., Carlino, E. & Pollo, A. 2011 How placebos change the patient's brain. Neuropsychopharmacology Rev. 36, 339-354. (doi:10.1038/npp.2010.81)
4. Benedetti, F. 2008 Mechanisms of placebo and placeborelated effects across diseases and treatments. Annu. Rev. Pharmacol. Toxicol 48, 33-60. (doi:10.1146/annurev. pharmtox.48.113006.094711)
5. Price, D. D., Finniss, D. G. & Benedetti, F. 2008 A comprehensive review of the placebo effects: recent advances and current thought. Annu. Rev. Psychol 59, 565-590. (doi:10.1146/annurev.psych.59.113006.095941)
6. Enck, P., Benedetti, F. & Schedlowski, M. 2008 New insights into the placebo and nocebo responses. Neuron 59, 195-206. (doi:10.1016/j.neuron.2008.06.030)
7. Zubieta, J. K. & Stohler, C. S. 2009 Neurobiologicalmechanisms of placebo responses. Ann. N Y Acad. Sci. 1156, 198-210. (doi:10.1111/j.1749-6632.2009.04424.x)
8. Benedetti, F. 2007 Placebo and endogenous mechanisms of analgesia. Handb. Exp. Pharmacol. 177, 393-413. (doi:10.1007/978-3-540-33823-9_14)
9. Colloca, L., Benedetti, F. & Porro, C. A. 2008 Experimental designs and brain mapping approaches for studying the placebo analgesic effect. Eur. J. Appl. Physiol. 102, 371-380. (doi:10.1007/s00421-007-0593-6)
10. Levine, J. D., Gordon, N. C. & Fields, H. L. 1978 The mechanisms of placebo analgesia. Lancet 2, 654-657. (doi:10.1016/S0140-6736(78)92762-9)
11. Fields, H. 2004 State-dependent opioid control of pain. Nat. Rev. Neurosci. 5, 565-575. (doi:10.1038/nrn1431)
12. Millan, M. J. 2002 Descending control of pain. Prog.Neurobiol. 66, 355-474. (doi:10.1016/S0301-0082(02)00009-6)
13. Amanzio, M. & Benedetti, F. 1999 Neuropharmacological dissection of placebo analgesia: expectation-activated opioid systems versus conditioning-activated specific sub-systems. J. Neurosci. 19, 484-494.
14. Lipman, J. J., Miller, B. E., Mays, K. S., Miller, M. N., North, W. C. & Byrne, W. L. 1990 Peak B endorphin concentration in cerebrospinal fluid: reduced in chronic pain patients and increased during the placebo response. Psychopharmacology 102, 112-116. (doi:10.1007/BF02245754)
15. Benedetti, F., Amanzio, M., Baldi, S., Casadio, C. & Maggi, G. 1999 Inducing placebo respiratory depressant responses in humans via opioid receptors. Eur. J. Neurosci. 11, 625-631. (doi:10.1046/j.1460-9568.1999.00465.x)
16. Pollo, A., Vighetti, S., Rainero, I. & Benedetti, F. 2003 Placebo analgesia and the heart. Pain 102, 125-133. (doi:10.1016/s0304-3959(02)00345-7)
17. Benedetti, F., Arduino, C. & Amanzio, M. 1999 Somatotopic activation of opioid systems by target-directed expectations of analgesia. J. Neurosci. 19, 3639-3648.
18. Rainville, P. & Duncan, G. H. 2006 Functional brain imaging of placebo analgesia: methodological challenges and recommendations. Pain 121, 177-180. (doi:10.1016/j.pain.2006.01.011)
19. Kong, J., Kaptchuk, T. J., Polich, G., Kirsch, I. & Gollub, R. L. 2007 Placebo analgesia: findings from brain imaging studies and emerging hypothesis. Rev. Neurosci. 18, 173-190.
20. Petrovic, P., Kalso, E., Petersson, K. M. & Ingvar, M. 2002 Placebo and opioid analgesia-imaging a shared neuronal network. Science 295, 1737-1740. (doi:10.1126/science.1067176)
21. Petrovic, P., Kalso, E., Petersson, K. M., Andersson, J., Fransson, P. & Ingvar, M. 2010 A prefrontal nonopioid mechanism in placebo analgesia. Pain 150, 59-65. (doi:10.1016/j.pain.2010.03.011)
22. Zubieta, J.K., Bueller, J.A., Jackson, L.R., Scott, D. J., Xu, Y., Koeppe, R. A., Nichols, T. E. & Stohler, C. S. 2005 Placebo effects mediated by endogenous opioid activity on m-opioid receptors. J. Neurosci. 25, 7754-7762. (doi:10.1523/JNEUROSCI.0439-05.2005)
23. Bingel, U., Lorenz, J., Schoell, E.,Weiller, C. & Büchel, C. 2006 Mechanisms of placebo analgesia: rACC recruitment of a subcortical antinociceptive network. Pain 120, 8-15. (doi:10.1016/j.pain.2005.08.027)
24. Eippert, F., Bingel, U., Schoell, E. D., Yacubian, J., Klinger, R., Lorenz, J. & Bü chel, C. 2009 Activation of the opioidergic descending pain control system underlies placebo analgesia. Neuron 63, 533-543. (doi:10.1016/j.neuron.2009.07.014)
25. Wager, T. D., Scott, D. J. & Zubieta, J. K. 2007 Placebo effects on human m-opioid activity during pain. Proc. Natl Acad. Sci. USA 104, 11056-11061. (doi:10.1073/pnas.0702413104)
26. Matre, D., Casey, K. L. & Knardahl, S. 2006 Placeboinduced changes in spinal cord pain processing. J. Neurosci. 26, 559-563. (doi:10.1523/JNEUROSCI.4218-05.2006)
27. Goffaux, P., Redmond, W. J., Rainville, P. & Marchand, S. 2007 Descending analgesia-when the spine echoes what the brain expects. Pain 130, 137-143. (doi:10.1016/j.pain.2006.11.011)
28. Eippert, F., Finsterbusch, J., Bingel, U. & Büchel, C. 2009 Direct evidence for spinal cord involvement in placebo analgesia. Science 326, 404. (doi:10.1126/science.1180142)
29. Benedetti, F., Arduino, C., Costa, S., Vighetti, S., Tarenzi, L., Rainero, I. & Asteggiano, G. 2006 Loss of expectationrelated mechanisms in Alzheimer's disease makes analgesic therapy less effective. Pain 121, 133-144. (doi:10.1016/j.pain.2005.12.016)
30. Krummenacher, P., Candia, V., Folkers, G., Schedlowski, M. & Schönbächler, G. 2010 Prefrontal cortex modulates placebo analgesia. Pain 148, 368-374. (doi:10.1016/j.pain.2009.09.033)
31. Benedetti, F., Amanzio, M. & Maggi, G. 1995 Potentiation of placebo analgesia by proglumide. Lancet 346, 1231. (doi:10.1016/S0140-6736(95)92938-X)
32. Benedetti, F. 1996 The opposite effects of the opiate antagonist naloxone and the cholecystokinin antagonist proglumide on placebo analgesia. Pain 64, 535-543. (doi:10.1016/0304-3959(95)00179-4)
33. Noble, F. & Roques, B. P. 2003 The role of CCK2 receptors in the homeostasis of the opioid system. Drugs Today 39, 897-908. (doi:10.1358/dot.2003.39.11.799467)
34. Benedetti, F., Lanotte, M., Lopiano, L. & Colloca, L. 2007 When words are painful: unraveling the mechanisms of the nocebo effect. Neuroscience 147, 260-271. (doi:10.1016/j.neuroscience.2007.02.020)
35. Benedetti, F., Amanzio, M., Casadio, C., Oliaro, A. & Maggi, G. 1997 Blockade of nocebo hyperalgesia by the cholecystokinin antagonist proglumide. Pain 71, 135-140. (doi:10.1016/S0304-3959(97)03346-0)
36. Benedetti, F., Amanzio, M., Vighetti, S. & Asteggiano, G. 2006 The biochemical and neuroendocrine bases of the hyperalgesic nocebo effect. J. Neurosci. 26, 12014-12022. (doi:10.1523/JNEUROSCI.2947-06.2006)
37. Hebb, A. L.O., Poulin, J.-F., Roach, S. P., Zacharko, R.M. & Drolet, G. 2005 Cholecystokinin and endogenous opioid peptides: interactive influence on pain, cognition, and emotion. Prog. Neuropsychopharmacol. Biol. Psychiatry. 29, 1225-1238. (doi:10.1016/j.pnpbp.2005.08.008)
38. Gospic, K., Gunnarsson, T., Fransson, P., Ingvar, M., Lindefors, N. & Petrovic, P. 2008 Emotional perception modulated by an opioid and a cholecystokinin agonist. Psychopharmacology 197, 295-307. (doi:10.1007/s00213-007-1032-4)
39. de la Fuente-Fernández, R., Phillips, A.F., Zamburlini, M., Sossi, V., Calne, D. B., Ruth, T. J. & Stoessl, A. J. 2002 Dopamine release in human ventral striatum and expectation of reward. Behav. Brain Res. 96, 393-402. (doi:10.1016/S0166-4328(02)00130-4)
40. Scott, D. J., Stohler, C. S., Egnatuk, C. M., Wang, H., Koeppe, R. A. & Zubieta, J. K. 2007 Individual differences in reward responding explain placebo-induced expectations and effects. Neuron 55, 325-336. (doi:10.1016/j.neuron.2007.06.028)
41. Scott, D. J., Stohler, C. S., Egnatuk, C. M., Wang, H., Koeppe, R. A. & Zubieta, J. K. 2008 Placebo and nocebo effects are defined by opposite opioid and dopaminergic responses. Arch. Gen. Psychiatry 65, 1225-1226. (doi:10.1001/archgenpsychiatry.2007.34)
42. Kaasinen, V., Aalto, S., Nagren, K. & Rinne, J. O. 2004 Expectation of caffeine induces dopaminergic responses in humans. Eur. J. Neurosci. 19, 2352-2356. (doi:10.1111/j.1460-9568.2004.03310.x)
43. Blandini, F., Nappi, G., Tassorelli, C. & Martignoni, E. 2000 Functional changes of the basal ganglia circuitry in Parkinson's disease. Prog. Neurobiol. 62, 63-88. (doi:10.1016/S0301-0082(99)00067-2)
44. de la Fuente-Fernández, R., Ruth, T. J., Sossi, V., Schulzer, M., Calne, D. B. & Stoessl, A. J. 2001 Expectation and dopamine release: mechanism of the placebo effect in Parkinson's disease. Science 293, 1164-1166. (doi:10.1126/science.1060937)
45. Strafella, A. P., Ko, J. H. & Monchi, O. 2006 Therapeutic application of transcranial magnetic stimulation in Parkinson's disease: the contribution of expectation. Neuroimage 31, 1666-1672. (doi:10.1016/j.neuroimage.2006.02.005)
46. Pollo, A., Torre, E., Lopiano, L., Rizzone, M., Lanotte, M., Cavanna, A., Bergamasco, B. & Benedetti, F. 2002 Expectation modulates the response to subthalamic nucleus stimulation in Parkinsonian patients. Neuroreport 13, 1383-1386. (doi:10.1097/00001756-200208070-00006)
47. Stefani, A. et al. 2002 Subdyskinetic apomorphine responses in globus pallidus and subthalamus of parkinsonian patients: lack of clear evidence for the 'indirect pathway'. Clin. Neurophysiol. 113, 91-100. (doi:10.1016/S1388-2457(01)00683-6)
48. Benedetti, F., Colloca, L., Torre, E., Lanotte, M., Melcarne, A., Pesare, M., Bergamasco, B. & Lopiano, L. 2004 Placebo-responsive Parkinson patients show decreased activity in single neurons of subthalamic nucleus. Nat. Neurosci. 7, 587-588. (doi:10.1038/nn1250)
49. Benedetti, F., Lanotte, M., Colloca, L., Ducati, A., Zibetti, M. & Lopiano, L. 2009 Electrophysiological properties of thalamic, subthalamic and nigral neurons during the anti-parkinsonian placebo response. J. Physiol. 587, 3869-3883. (doi:10.1113/jphysiol.2009.169425)
50. Benedetti, F., Pollo, A., Lopiano, L., Lanotte, M., Vighetti, S. & Rainero, I. 2003 Conscious expectation and unconscious conditioning in analgesic, motor and hormonal placebo/nocebo responses. J. Neurosci. 23, 4315-4323.
51. Stockhorst, U., Steingruber, H. J. & Scherbaum, W.A. 2000 Classically conditioned responses following repeated insulin and glucose administration in humans. Behav. Brain Res. 110, 143-159. (doi:10.1016/S0166-4328(99)00192-8)
52. Sabbioni, M. E. E., Bovbjerg, D. H., Mathew, S., Sikes, C., Lasley, B. & Stokes, P. E. 1997 Classically conditioned changes in plasma cortisol levels induced by dexamethasone in healthy men. FASEB J. 11, 1291-1296.
53. Vits, S., Cesko, E., Enck, P., Hillen, U., Schadendorf, D. & Schedlowski, M. 2011 Behavioral conditioning as the mediator of placebo responses in the immune system. Phil. Trans. R. Soc. B 366, 1799-1807. (doi:10.1098/rstb.2010.0392)
54. Schedlowski, M. & Pacheco-López, G. 2010 The learned immune response: Pavlov and beyond. Brain Behav. Immun. 24, 176-185. (doi:10.1016/j.bbi.2009.08.007)
55. Giang, D. W., Goodman, A. D., Schiffer, R. B., Mattson, D. H., Petrie, M., Cohen, N. & Ader, R. 1996 Conditioning of cyclophosphamide-induced leukopenia in humans. J. Neuropsychiatry Clin. Neurosci. 8, 194-201.
56. Goebel, M. U. et al. 2002 Behavioral conditioning of immunosuppression is possible in humans. FASEB J. 16, 1869-1873. (doi:10.1096/fj.02-0389com)
57. Pacheco-López, G., Riether, C., Doenlen, R., Engler, H., Niemi, M. B., Engler, A., Kavelaars, A., Heijnen, C. J. & Schedlowski, M. 2008 Calcineurin inhibition in splenocytes induced by Pavlovian conditioning. FASEB J. 23, 1161-1167. (doi:10.1096/fj.08-115683)
58. Pacheco-López, G., Niemi, M. B., Kou, W., Harting, M., Fandrey, J. & Schedlowski, M. 2005 Neural substrates for behaviourally conditioned immunosuppression in the rat. J. Neurosci. 25, 2330-2337. (doi:10.1523/JNEUROSCI.4230-04.2005)
59. Tracey, K. J. 2002 The inflammatory reflex. Nature 420, 853-859. (doi:10.1038/nature01321)
60. Tracey, K. J. 2009 Reflex control of immunity. Nat. Rev. Immunol. 9, 419-428. (doi:10.1038/nri2566)
61. Tuohy, V. K. 2005 The neocortical-immune axis. J. Neuroimmunol. 158, 1-2. (doi:10.1016/j.jneuroim.2004.10.004)
62. Lanotte, M., Lopiano, L., Torre, E., Bergamasco, B., Colloca, L. & Benedetti, F. 2005 Expectation enhances autonomic responses to stimulation of the human subthalamic limbic region. Brain Behav. Immun. 19, 500-509. (doi:10.1016/j.bbi.2005.06.004)
63. Meissner, K., Kohls, N. & Colloca, L. 2011 Introduction to placebo effects in medicine: mechanisms and clinical implications. Phil. Trans. R. Soc. B 366, 1783-1789. (doi:10.1098/rstb.2010.0414)
64. Ariel, G. & Saville, W. 1972 Anabolic steroids: the physiological effects of placebos. Med. Sci. Sports Exerc. 4, 124-126.
65. Maganaris, C. N., Collins, D. & Sharp, M. 2000 Expectancy effects and strength training: do steroids make a difference? Sport Psychol. 14, 272-278.
66. Kalasountas, V., Reed, J. & Fitzpatrick, J. 2007 The effect of placebo-induced changes in expectancies onmaximal force production in college students. J. Appl. Sport Psychol. 19, 116-124. (doi:10.1080/10413200601123736)
67. Ross, S., Krugman, A. D., Lyerly, S. B. & Clyde, D. J. 1962 Drugs and placebos: a model design. Psychol. Rep. 10, 383-392. (doi:10.2466/PR0.10.2.383-392)
68. Clark, V.R., Hopkins, W. G., Hawley, J. A. & Burke, L.M. 2000 Placebo effect of carbohydrate feedings during a 40-km cycling time trial. Med. Sci. Sports Exerc. 32, 1642-1647. (doi:10.1097/00005768-200009000-00019)
69. Kirsch, I. & Weixel, L. J. 1988 Double-blind versus deceptive administration of a placebo. Behav. Neurosci. 102, 319-323. (doi:10.1037/0735-7044.102.2.319)
70. Pollo, A., Amanzio, M., Arslanian, A., Casadio, C., Maggi, G. & Benedetti, F. 2001 Response expectancies in placebo analgesia and their clinical relevance. Pain 93, 77-83. (doi:10.1016/S0304-3959(01)00296-2)
71. Beedie, C. J., Stuart, E. M., Coleman, D. A. & Foad, A. J. 2006 Placebo effect of caffeine in cycling performance. Med. Sci. Sports Exerc. 38, 2159-2164. (doi:10.1249/01.mss.0000233805.56315.a9)
72. McNaughton, L. R. 1992 Sodium bicarbonate ingestion and its effects on anaerobic exercise of various durations. J. Sport Sci. 10, 425-435. (doi:10.1007/BF00376437)
73. McClung, M. & Collins, D. 2007 'Because I know it will!': placebo effects of an ergogenic aid on athletic performance. J. Sport Exerc. Psychol. 29, 382-394.
74. Foad, A. J., Beedie, C. J. & Coleman, D. A. 2008 Pharmachological and psychological effects of caffeine ingestion in 40-km cycling performance. Med. Sci. Sport Exerc. 40, 158-165.
75. Beedie, C. J., Foad, A. J. & Coleman, D. A. 2008 Identification of placebo responsive participants in 40 km laboratory cycling performance. J. Sports Sci. Med. 7, 166-175.
76. Beedie, C. J., Coleman, D. A. & Foad, A. J. 2007 Positive and negative placebo effects resulting from the deceptive administration of an ergogenic aid. Int. J. Sport Nutr. Exerc. Metab. 17, 259-269.
77. Benedetti, F., Pollo, A. & Colloca, L. 2007 Opioidmediated placebo responses boost pain endurance and physical performance-is it doping in sport competitions? J. Neurosci. 27, 11934-11939. (doi:10.1523/JNEUROSCI.3330-07.2007)
78. Voudouris, N. J., Peck, C. L. & Coleman, G. 1989 Conditioned response models of placebo phenomena: further support. Pain 38, 109-116. (doi:10.1016/0304-3959(89)90080-8)
79. Pollo, A., Carlino, E. & Benedetti, F. 2008 The topdown influence of ergogenic placebos on muscle work and fatigue. Eur. J. Neurosci. 28, 379-388. (doi:10.1111/j.1460-9568.2008.06344.x)
80. Kirsch, I., Lynn, S. J., Vigorito, M. & Miller, R. R. 2004 The role of cognition in classical and operant conditioning. J. Clin. Psychol. 60, 369-392. (doi:10.1002/jclp.10251)
81. Lambert, E. V., St Clair Gibson, A. & Noakes, T. D. 2005 Complex systems model of fatigue: integrative homoeostatic control of peripheral physiological systems during exercise in humans. Br. J. Sports Med. 39, 52-62. (doi:10.1136/bjsm.2003.011247)
82. Hampson, D. B., St Clair Gibson, A., Lambert, M. I. & Noakes, T. D. 2001 The influence of sensory cues on the perception of exertion during exercise and central regulation of exercise performance. Sports Med. 31, 935-952. (doi:10.2165/00007256-200131130-00004)